Skip to main content

Table 3 Clinical Bentley analysis of circPTPN22

From: As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway

Parameter No. of patients circPTPN22(high) circPTPN22(low) P-value
Sex
 Male 72 34 38 0.456
 Female 48 26 22
Age (years)
 <60 43 18 25 0.183
 ≥60 77 42 35
Tumor size
 <5 72 27 45 0.001***
 ≥5 48 33 15
Differentiation grade
 Well-moderate 56 34 22 0.028*
 Poor-undifferentiation 64 26 38
T stage
 T1–T2 68 24 44 < 0.0001****
 T3–T4 52 36 16
Lymph node status     
 Positive 75 24 51 < 0.0001****
 Negative 45 36 9
TNM stage
 I–II 52 15 37 < 0.0001****
 III–IV 68 45 23
Nerve/vascular invasion
 Positive 63 28 35 0.201
 Negative 57 32 25
  1. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001